Tokyo District Court Dismisses Ajinomoto's Patent Infringement Case against Chugai Pharmaceutical.Tokyo, Japan, Mar 22, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Chugai Pharmaceutical announced on March 22 that the Tokyo District Court Tokyo District Court (東京地方裁判所; Tōkyō Chihō Saibansho) is a district court in Kasumigaseki, Chiyoda, Tokyo, Japan. See also
Ajinomoto alleged that Chugai Pharmaceutical had infringed upon its patent in the process of manufacturing Epogin and Neutrogin, two ethical drugs marketed by Chugai Pharmaceutical. Accordingly, Ajinomoto sought 3 billion yen ($25.4 mil) and statutory interest as compensation for the damage. The Japanese Patent Office (JPO JPO Joint Program Office JPO Japanese Patent Office JPO Journal of Prosthetics and Orthotics JPO Journal of Physical Oceanography JPO Juvenile Probation Officer JPO Jump If Parity Odd JPO Joint Pipeline Office JPO Joint Planning Office ) had already declared the relevant patent invalid as of September 2005. Currently, the revocation suit against the JPO decision is pending at the Intellectual Property High Court. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion